Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRX 194204 in advanced NSCLC
NCT00964132Phase 2Unknown
- Sponsor
- Nurx
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of irx4204 in non-small cell lung cancer (NSCLC), sponsored by Nurx. Status: unknown.
02
Drugs
irx4204
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00964132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964132.